Sign in
Back
American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis
Journal article   Peer reviewed

American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis

Paul S Jellinger, Donald A Smith, Adi E Mehta, Om Ganda, Yehuda Handelsman, Helena W Rodbard, Mark D Shepherd, John A Seibel and AACE Task Force for Management of Dyslipidemia and Prevention of Atherosclerosis
Endocrine practice, Vol.18 Suppl 1(1), pp.1-78
2012-03
DOI: https://doi.org/10.4158/ep.18.s1.1
PMID: 22522068

Abstract

United States - epidemiology Humans Male Motor Activity Combined Modality Therapy - economics Cost Savings Atherosclerosis - economics Atherosclerosis - etiology Lipids - blood Dyslipidemias - therapy Adult Female Dyslipidemias - economics Child Hypolipidemic Agents - adverse effects Risk Factors Insulin Resistance Health Care Costs Hypolipidemic Agents - economics Diet, Fat-Restricted Adolescent Dyslipidemias - metabolism Hypolipidemic Agents - therapeutic use Drug Monitoring Atherosclerosis - prevention & control Dyslipidemias - physiopathology Smoking Cessation

Metrics

4 Record Views

Details